SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027464
Filing Date
2018-11-06
Accepted
2018-11-06 16:36:40
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eidx-10q_20180930.htm 10-Q 1663087
2 EX-31.1 eidx-ex311_6.htm EX-31.1 17877
3 EX-31.2 eidx-ex312_8.htm EX-31.2 17954
4 EX-32.1 eidx-ex321_7.htm EX-32.1 9923
5 EX-32.2 eidx-ex322_9.htm EX-32.2 9931
  Complete submission text file 0001564590-18-027464.txt   6323359

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eidx-20180930.xml EX-101.INS 1264079
7 XBRL TAXONOMY EXTENSION SCHEMA eidx-20180930.xsd EX-101.SCH 63967
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eidx-20180930_cal.xml EX-101.CAL 32340
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eidx-20180930_def.xml EX-101.DEF 199849
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eidx-20180930_lab.xml EX-101.LAB 442245
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eidx-20180930_pre.xml EX-101.PRE 335090
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38533 | Film No.: 181163497
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1